CN Stock MarketDetailed Quotes

688163 Shanghai Serum Bio-Technology

Watchlist

15.20
-0.27-1.75%

Market Closed Sep 13 15:00 CST

1.64BMarket Cap37.25P/E (TTM)

Shanghai Serum Bio-Technology Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

Assets

Current assets

Money funds

65.90%172.34M

-4.50%124.09M

-70.74%150.92M

8.07%122M

-77.19%103.88M

-29.62%129.95M

345.07%515.73M

20.53%112.89M

700.19%455.42M

--184.62M

Transactional financial assets

-10.55%651.97M

-7.91%722.26M

73.03%722.59M

-9.07%743.12M

65.43%728.84M

1.82%784.26M

541.02%417.62M

918.68%817.24M

608.78%440.59M

--770.23M

Notes receivable and accounts receivable

14.20%59.48M

114.18%38.5M

194.73%22.63M

95.53%42.95M

77.64%52.08M

-27.47%17.97M

-19.90%7.68M

14.98%21.96M

-31.45%29.32M

--24.78M

-Accounts receivable

14.20%59.48M

114.18%38.5M

194.73%22.63M

95.53%42.95M

77.64%52.08M

-27.47%17.97M

-19.90%7.68M

14.98%21.96M

-31.45%29.32M

--24.78M

Other receivables (including interest and dividends)

-48.09%520.06K

9.13%1.11M

-27.50%712.42K

-16.19%1.07M

-4.25%1M

-51.06%1.02M

-84.28%982.66K

-81.11%1.27M

-80.88%1.05M

--2.08M

-Other receivable

-48.09%520.06K

----

-27.50%712.42K

----

-4.25%1M

----

-84.28%982.66K

----

-80.88%1.05M

----

Advance payment

40.19%1.52M

22.29%1.11M

190.54%1.49M

243.13%3.28M

23,273.12%1.09M

2,639.43%906.95K

1,540.98%512.61K

-47.38%956.06K

-99.51%4.65K

--33.11K

Inventories

-12.90%42.85M

-15.15%47.44M

-17.94%44.75M

-13.83%44.04M

-7.02%49.2M

12.96%55.91M

10.88%54.53M

3.44%51.11M

3.20%52.92M

--49.49M

Other current assets

--9.57M

--5.84M

--5.83M

----

-86.34%553.5K

806.75%738K

--1.85M

Total current assets

0.23%938.25M

-5.02%940.36M

-4.83%948.93M

-4.92%956.46M

-4.48%936.09M

-4.17%990.01M

302.15%997.05M

294.49%1.01B

346.23%980.03M

--1.03B

Non Current assets

Fixed assets

93.58%106.33M

----

-0.49%58.35M

----

-3.24%54.93M

----

0.54%58.64M

----

-6.13%56.77M

----

Constru in process

-81.62%8.76M

----

26.59%54.6M

----

64.23%47.67M

----

46.13%43.14M

----

80.59%29.03M

----

Productive biological assets

-8.63%4.4M

1.12%4.58M

4.00%3.46M

29.11%5.05M

32.71%4.82M

47.03%4.53M

28.05%3.33M

1.94%3.91M

2.33%3.63M

--3.08M

Intangible assets

-2.35%23.41M

-1.90%23.6M

-1.86%23.79M

1.27%23.79M

1.37%23.97M

1.05%24.06M

1.13%24.24M

-3.10%23.49M

-3.51%23.65M

--23.81M

Long deferred expense

-24.13%754.62K

-22.75%814.61K

-21.53%874.6K

-20.43%934.58K

-19.44%994.57K

-18.54%1.05M

-17.71%1.11M

-16.96%1.17M

-16.27%1.23M

--1.29M

Deferred tax assets

-3.94%9.67M

63.52%9.96M

6.72%9.91M

95.39%9.79M

79.39%10.06M

50.78%6.09M

82.32%9.29M

-2.26%5.01M

-0.50%5.61M

--4.04M

Usufruct assets

-7.69%10.95M

-7.55%11.18M

-7.41%11.41M

-7.27%11.64M

-7.14%11.86M

-7.02%12.09M

-6.90%12.32M

-6.78%12.55M

-6.67%12.78M

--13M

Other non current assets

2,058.88%14.2M

0.00%22.5K

2,348.00%550.8K

--22.5K

448.31%657.97K

-97.87%22.5K

----

--120K

--1.06M

Total non current assets

13.50%193.38M

10.00%182.61M

5.97%179.54M

10.20%172.68M

11.92%170.38M

8.60%166.02M

9.34%169.43M

4.41%156.69M

3.68%152.23M

--152.86M

Total assets

2.27%1.13B

-2.86%1.12B

-3.26%1.13B

-2.88%1.13B

-2.28%1.11B

-2.52%1.16B

189.53%1.17B

187.02%1.16B

208.98%1.13B

--1.19B

Liabilities

Current liabilities

Notes payable and accounts payable

-20.07%2.25M

-24.08%3.4M

-14.96%3.64M

9.47%3.79M

-28.83%2.81M

12.67%4.48M

72.84%4.28M

6.97%3.46M

84.07%3.95M

--3.97M

-Accounts payable

-20.07%2.25M

-24.08%3.4M

-14.96%3.64M

9.47%3.79M

-28.83%2.81M

12.67%4.48M

72.84%4.28M

6.97%3.46M

84.07%3.95M

--3.97M

Contract liabilities

-30.05%1.81M

317.14%2.64M

47.33%2.93M

-15.32%3M

-26.88%2.59M

53.73%633.36K

38.32%1.99M

20.64%3.54M

38.92%3.55M

--411.99K

Salaries payable

3.83%4.87M

-15.74%1.94M

-0.23%7.69M

-32.65%2.58M

44.97%4.69M

140.48%2.3M

32.53%7.7M

-3.83%3.83M

-7.33%3.24M

--955.02K

Taxs payable

9.18%2.51M

-56.86%1.48M

-88.74%460.64K

-70.34%2.44M

-76.91%2.3M

14.36%3.42M

190.86%4.09M

26.61%8.22M

228.19%9.97M

--2.99M

Other payable (including interest and dividends)

-18.92%5.72M

69.71%7.54M

27.78%9.43M

1.86%6.95M

7.59%7.05M

24.27%4.44M

43.35%7.38M

21.43%6.82M

29.42%6.55M

--3.58M

-Dividend payable

12.12%18.5K

83.33%16.5K

--9K

444.46%9K

----

-Other payable

-18.99%5.7M

----

27.71%9.42M

----

7.49%7.03M

----

43.22%7.37M

----

29.28%6.54M

----

Non current liabilities due within one year

-43.49%775.86K

-44.76%758.43K

0.00%1.37M

-5.61%1.37M

0.00%1.37M

3.61%1.37M

0.00%1.37M

-29.37%1.45M

--1.37M

Other current liabilities

-30.05%54.4K

680.84%97.79K

44.97%86.39K

-2.66%76.52K

-25.17%77.76K

-73.31%12.52K

38.32%59.59K

-10.76%78.61K

32.31%103.91K

--46.93K

Total current liabilities

-13.91%17.99M

7.17%17.85M

-7.02%24.99M

-26.08%20.2M

-27.47%20.9M

24.98%16.65M

52.27%26.87M

15.18%27.33M

56.34%28.81M

--13.33M

Current liabilities

Deferred tax liabilities

-4.10%5.33M

109.94%5.45M

-4.02%5.45M

114.34%5.56M

0.00%2.59M

118.73%5.67M

0.00%2.59M

--2.59M

Lease liabilities

-6.57%11.81M

-0.95%12.36M

-0.89%12.2M

-5.59%12.11M

-4.51%12.64M

-5.10%12.47M

-5.46%12.31M

-4.65%12.83M

-0.09%13.24M

--13.15M

Total non current liabilities

-5.82%17.14M

18.14%17.8M

-1.88%17.65M

14.58%17.67M

14.97%18.2M

-4.26%15.07M

15.17%17.98M

-3.89%15.42M

-0.08%15.83M

--15.74M

Total liabilities

-10.14%35.13M

12.38%35.65M

-4.96%42.63M

-11.41%37.87M

-12.42%39.1M

9.15%31.72M

34.86%44.86M

7.48%42.75M

30.26%44.64M

--29.06M

Shareholders equity

Paid-in capital

0.00%108.22M

33.34%108.22M

--108.22M

Capital reserve funds

0.76%878.09M

0.00%871.49M

666.99%871.49M

--871.49M

Surplus reserve funds

10.12%45.82M

18.58%41.61M

26.98%35.09M

--35.09M

Retained profit

39.77%64.38M

-46.41%55.19M

-46.45%53.71M

-33.46%69.95M

-36.75%46.06M

-27.52%102.99M

-28.22%100.31M

-26.42%105.13M

-33.66%72.82M

--142.1M

Shareholders equity without minority interests

2.73%1.1B

-3.29%1.09B

-3.19%1.09B

-2.56%1.09B

-1.86%1.07B

-2.82%1.12B

203.45%1.12B

206.57%1.12B

227.42%1.09B

--1.16B

Total shareholder equity

2.73%1.1B

-3.29%1.09B

-3.19%1.09B

-2.56%1.09B

-1.86%1.07B

-2.82%1.12B

203.45%1.12B

206.57%1.12B

227.42%1.09B

--1.16B

Total liabilityies and equity

2.27%1.13B

-2.86%1.12B

-3.26%1.13B

-2.88%1.13B

-2.28%1.11B

-2.52%1.16B

189.53%1.17B

187.02%1.16B

208.98%1.13B

--1.19B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianzhu International Accounting Firm (Special General Partnership)

	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022
Assets
Current assets
Money funds	65.90%172.34M	-4.50%124.09M	-70.74%150.92M	8.07%122M	-77.19%103.88M	-29.62%129.95M	345.07%515.73M	20.53%112.89M	700.19%455.42M	--184.62M
Transactional financial assets	-10.55%651.97M	-7.91%722.26M	73.03%722.59M	-9.07%743.12M	65.43%728.84M	1.82%784.26M	541.02%417.62M	918.68%817.24M	608.78%440.59M	--770.23M
Notes receivable and accounts receivable	14.20%59.48M	114.18%38.5M	194.73%22.63M	95.53%42.95M	77.64%52.08M	-27.47%17.97M	-19.90%7.68M	14.98%21.96M	-31.45%29.32M	--24.78M
-Accounts receivable	14.20%59.48M	114.18%38.5M	194.73%22.63M	95.53%42.95M	77.64%52.08M	-27.47%17.97M	-19.90%7.68M	14.98%21.96M	-31.45%29.32M	--24.78M
Other receivables (including interest and dividends)	-48.09%520.06K	9.13%1.11M	-27.50%712.42K	-16.19%1.07M	-4.25%1M	-51.06%1.02M	-84.28%982.66K	-81.11%1.27M	-80.88%1.05M	--2.08M
-Other receivable	-48.09%520.06K	----	-27.50%712.42K	----	-4.25%1M	----	-84.28%982.66K	----	-80.88%1.05M	----
Advance payment	40.19%1.52M	22.29%1.11M	190.54%1.49M	243.13%3.28M	23,273.12%1.09M	2,639.43%906.95K	1,540.98%512.61K	-47.38%956.06K	-99.51%4.65K	--33.11K
Inventories	-12.90%42.85M	-15.15%47.44M	-17.94%44.75M	-13.83%44.04M	-7.02%49.2M	12.96%55.91M	10.88%54.53M	3.44%51.11M	3.20%52.92M	--49.49M
Other current assets	--9.57M	--5.84M	--5.83M	----	----	----	----	-86.34%553.5K	806.75%738K	--1.85M
Total current assets	0.23%938.25M	-5.02%940.36M	-4.83%948.93M	-4.92%956.46M	-4.48%936.09M	-4.17%990.01M	302.15%997.05M	294.49%1.01B	346.23%980.03M	--1.03B
Non Current assets
Fixed assets	93.58%106.33M	----	-0.49%58.35M	----	-3.24%54.93M	----	0.54%58.64M	----	-6.13%56.77M	----
Constru in process	-81.62%8.76M	----	26.59%54.6M	----	64.23%47.67M	----	46.13%43.14M	----	80.59%29.03M	----
Productive biological assets	-8.63%4.4M	1.12%4.58M	4.00%3.46M	29.11%5.05M	32.71%4.82M	47.03%4.53M	28.05%3.33M	1.94%3.91M	2.33%3.63M	--3.08M
Intangible assets	-2.35%23.41M	-1.90%23.6M	-1.86%23.79M	1.27%23.79M	1.37%23.97M	1.05%24.06M	1.13%24.24M	-3.10%23.49M	-3.51%23.65M	--23.81M
Long deferred expense	-24.13%754.62K	-22.75%814.61K	-21.53%874.6K	-20.43%934.58K	-19.44%994.57K	-18.54%1.05M	-17.71%1.11M	-16.96%1.17M	-16.27%1.23M	--1.29M
Deferred tax assets	-3.94%9.67M	63.52%9.96M	6.72%9.91M	95.39%9.79M	79.39%10.06M	50.78%6.09M	82.32%9.29M	-2.26%5.01M	-0.50%5.61M	--4.04M
Usufruct assets	-7.69%10.95M	-7.55%11.18M	-7.41%11.41M	-7.27%11.64M	-7.14%11.86M	-7.02%12.09M	-6.90%12.32M	-6.78%12.55M	-6.67%12.78M	--13M
Other non current assets	2,058.88%14.2M	0.00%22.5K	2,348.00%550.8K	--22.5K	448.31%657.97K	-97.87%22.5K	-97.87%22.5K	----	--120K	--1.06M
Total non current assets	13.50%193.38M	10.00%182.61M	5.97%179.54M	10.20%172.68M	11.92%170.38M	8.60%166.02M	9.34%169.43M	4.41%156.69M	3.68%152.23M	--152.86M
Total assets	2.27%1.13B	-2.86%1.12B	-3.26%1.13B	-2.88%1.13B	-2.28%1.11B	-2.52%1.16B	189.53%1.17B	187.02%1.16B	208.98%1.13B	--1.19B
Liabilities
Current liabilities
Notes payable and accounts payable	-20.07%2.25M	-24.08%3.4M	-14.96%3.64M	9.47%3.79M	-28.83%2.81M	12.67%4.48M	72.84%4.28M	6.97%3.46M	84.07%3.95M	--3.97M
-Accounts payable	-20.07%2.25M	-24.08%3.4M	-14.96%3.64M	9.47%3.79M	-28.83%2.81M	12.67%4.48M	72.84%4.28M	6.97%3.46M	84.07%3.95M	--3.97M
Contract liabilities	-30.05%1.81M	317.14%2.64M	47.33%2.93M	-15.32%3M	-26.88%2.59M	53.73%633.36K	38.32%1.99M	20.64%3.54M	38.92%3.55M	--411.99K
Salaries payable	3.83%4.87M	-15.74%1.94M	-0.23%7.69M	-32.65%2.58M	44.97%4.69M	140.48%2.3M	32.53%7.7M	-3.83%3.83M	-7.33%3.24M	--955.02K
Taxs payable	9.18%2.51M	-56.86%1.48M	-88.74%460.64K	-70.34%2.44M	-76.91%2.3M	14.36%3.42M	190.86%4.09M	26.61%8.22M	228.19%9.97M	--2.99M
Other payable (including interest and dividends)	-18.92%5.72M	69.71%7.54M	27.78%9.43M	1.86%6.95M	7.59%7.05M	24.27%4.44M	43.35%7.38M	21.43%6.82M	29.42%6.55M	--3.58M
-Dividend payable	12.12%18.5K	83.33%16.5K	83.33%16.5K	83.33%16.5K	83.33%16.5K	--9K	444.46%9K	444.46%9K	444.46%9K	----
-Other payable	-18.99%5.7M	----	27.71%9.42M	----	7.49%7.03M	----	43.22%7.37M	----	29.28%6.54M	----
Non current liabilities due within one year	-43.49%775.86K	-44.76%758.43K	-44.76%758.43K	0.00%1.37M	-5.61%1.37M	0.00%1.37M	3.61%1.37M	0.00%1.37M	-29.37%1.45M	--1.37M
Other current liabilities	-30.05%54.4K	680.84%97.79K	44.97%86.39K	-2.66%76.52K	-25.17%77.76K	-73.31%12.52K	38.32%59.59K	-10.76%78.61K	32.31%103.91K	--46.93K
Total current liabilities	-13.91%17.99M	7.17%17.85M	-7.02%24.99M	-26.08%20.2M	-27.47%20.9M	24.98%16.65M	52.27%26.87M	15.18%27.33M	56.34%28.81M	--13.33M
Current liabilities
Deferred tax liabilities	-4.10%5.33M	109.94%5.45M	-4.02%5.45M	114.34%5.56M	114.34%5.56M	0.00%2.59M	118.73%5.67M	0.00%2.59M	0.00%2.59M	--2.59M
Lease liabilities	-6.57%11.81M	-0.95%12.36M	-0.89%12.2M	-5.59%12.11M	-4.51%12.64M	-5.10%12.47M	-5.46%12.31M	-4.65%12.83M	-0.09%13.24M	--13.15M
Total non current liabilities	-5.82%17.14M	18.14%17.8M	-1.88%17.65M	14.58%17.67M	14.97%18.2M	-4.26%15.07M	15.17%17.98M	-3.89%15.42M	-0.08%15.83M	--15.74M
Total liabilities	-10.14%35.13M	12.38%35.65M	-4.96%42.63M	-11.41%37.87M	-12.42%39.1M	9.15%31.72M	34.86%44.86M	7.48%42.75M	30.26%44.64M	--29.06M
Shareholders equity
Paid-in capital	0.00%108.22M	0.00%108.22M	0.00%108.22M	0.00%108.22M	0.00%108.22M	0.00%108.22M	33.34%108.22M	33.34%108.22M	33.34%108.22M	--108.22M
Capital reserve funds	0.76%878.09M	0.76%878.09M	0.76%878.09M	0.00%871.49M	0.00%871.49M	0.00%871.49M	666.99%871.49M	666.99%871.49M	666.99%871.49M	--871.49M
Surplus reserve funds	10.12%45.82M	10.12%45.82M	10.12%45.82M	18.58%41.61M	18.58%41.61M	18.58%41.61M	18.58%41.61M	26.98%35.09M	26.98%35.09M	--35.09M
Retained profit	39.77%64.38M	-46.41%55.19M	-46.45%53.71M	-33.46%69.95M	-36.75%46.06M	-27.52%102.99M	-28.22%100.31M	-26.42%105.13M	-33.66%72.82M	--142.1M
Shareholders equity without minority interests	2.73%1.1B	-3.29%1.09B	-3.19%1.09B	-2.56%1.09B	-1.86%1.07B	-2.82%1.12B	203.45%1.12B	206.57%1.12B	227.42%1.09B	--1.16B
Total shareholder equity	2.73%1.1B	-3.29%1.09B	-3.19%1.09B	-2.56%1.09B	-1.86%1.07B	-2.82%1.12B	203.45%1.12B	206.57%1.12B	227.42%1.09B	--1.16B
Total liabilityies and equity	2.27%1.13B	-2.86%1.12B	-3.26%1.13B	-2.88%1.13B	-2.28%1.11B	-2.52%1.16B	189.53%1.17B	187.02%1.16B	208.98%1.13B	--1.19B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	Unqualified opinion	--	--	--	--	--	--	--
Auditor	--	--	Tianzhu International Accounting Firm (Special General Partnership)	--	--	--	Tianzhu International Accounting Firm (Special General Partnership)	--	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

688163 Shanghai Serum Bio-Technology

Shanghai Serum Bio-Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target